Health System Leaders Detail Challenges Shifting Infusion to Home Settings
In a Becker's Hospital Review report, oncology and pharmacy leaders at five health systems, including UC Davis Health, UC San Diego Health, UVA Health, Banner MD Anderson Cancer Center and Tufts Medical Center, describe how Medicare and commercial payer policies are pushing infusion toward lower-cost sites including patients' homes. Leaders say home infusion requires oncology-trained nurses, sterile compounding, round-the-clock pharmacy support, caregiver education and escalation plans for adverse reactions, and that reimbursement often fails to cover nursing, pharmacy, monitoring and care coordination beyond the drug itself. Systems vary in approach: UC Davis Health is expanding home infusion to more chemotherapy agents while keeping high-toxicity drugs in hospital settings, UVA Health uses home infusion sparingly, and Tufts Medical Center decides case by case based on safety and patient preference.